VITAVADA - VENTRE PLAT - JAMBES LEGERES
Food supplement declared in France, declaration No 2023-11-471
VITAVADA - VENTRE PLAT - JAMBES LEGERES, from BELLE & BIO (BELLE & BIO), is a food supplement declared in France. Status: withdrawal from the market announced for 9 February 2027. Main ingredients: Aesculus hippocastanum 210 mg per day, Vitis vinifera 200.1 mg per day, Ginkgo biloba 150 mg per day, Ruscus aculeatus 150 mg per day, Acacia seyal 129.9 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- BELLE & BIO (BELLE & BIO)
- Status
- Withdrawal from the market announced for 9 February 2027
- Form
- Capsule
- Daily dose
- 1 gélule et 3 gélules
- Directions for use
- prendre 1 gélule le matin et 3 gélules le soir
- Intended populations
- Men, Women
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, Taking anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Slimming / Flat stomach
Declaration 305935, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Aesculus hippocastanum L. | Graine | Poudre (de plantes séchées ou broyées) | 210 mg |
| Vitis vinifera L. | Feuille | Extrait sec aqueux | 200.1 mg |
| Ginkgo biloba L. | Feuille | Poudre (de plantes séchées ou broyées) | 150 mg |
| Ruscus aculeatus L. | Racine | Poudre (de plantes séchées ou broyées) | 150 mg |
| Acacia seyal Delile | Fibres | Poudre (de plantes séchées ou broyées) | 129.9 mg |
| Ribes nigrum L. | Feuille | Poudre (de plantes séchées ou broyées) | 120 mg |
| Lithothamnion calcareum (Pallas) Areschoug | Thalle | Poudre (de plantes séchées ou broyées) | 100 mg |
| Vaccinium myrtillus L. | Fruit | Extrait sec aqueux | 90 mg |
| Bambusa bambos (L.) Voss | Tige | Extrait sec hydroalcoolique | 30 mg |
| Bambusa vulgaris Schrad. | Tige | Extrait sec hydroalcoolique | 30 mg |
| Cichorium intybus L. | Racine | Poudre (de plantes séchées ou broyées) | 20 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Inuline | not declared |
Micro-organisms
| Strain | Per day |
|---|---|
| Lactobacillus Gasseri BIO 6369 | 5,000,000,000 (unit not declared) |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| zinc oxide | Zinc | 25 mg | 15 mg |
Additives
E460, E470b
Other ingredients
gélatine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé aux personnes sous traitement antidépresseur et traitement anti-diurétique, en cas d’allergie aux dérivés salicylés et d’intolérance aux anti-inflammatoires non-stéroïdiens, en cas d’insuffisance cardiaque ou rénale. Déconseillé femmes enceintes et allaitantes.Réservé à l'adulte.
Regulatory points
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Withdrawal from the market announced for 9 February 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Aesculus hippocastanum L.
Read the warning, when it applies and the studies cited
Horse Chestnut - Aesculus Hippocastanum
Route of administration: Oral (Bradley 2006; ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- Ginkgo biloba L.
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
Sources cited by Health Canada (3)
- Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Vaccinium myrtillus L.
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “VITAVADA - VENTRE PLAT - JAMBES LEGERES: composition and regulation”, https://compoatlas.com/en/supplements/products/305935-vitavada-ventre-plat-jambes-legeres, updated 15 November 2026.